Macquarie Group
HPTX

Macquarie Group’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Macquarie Group’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-45,969
Closed -$1.16M – 1673
2014
Q3 		$1.16M Buy
45,969
+4,736
+11% +$118K ﹤0.01% 1139
2014
Q2 		$1.08M Buy
41,233
+6,171
+18% +$159K ﹤0.01% 1189
2014
Q1 		$905K Buy
35,062
+388
+1% +$10.5K ﹤0.01% 1181
2013
Q4 		$701K Buy
34,674
+12,036
+53% +$283K ﹤0.01% 1215
2013
Q3 		$592K Buy
+22,638
New +$567K ﹤0.01% 1274

Other funds holding HPTX

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
HMPV
Highland Management Partners VII Cambridge, Massachusetts $5.57M AUM 94.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Macquarie Group's HPTX Position: Q4 2014 in Review

Macquarie Group sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q4 2014, closing a stake of 45,969 shares — an estimated $1.16M sold.

Macquarie Group first reported a position in HPTX in Q3 2013 and held it in 5 quarters. The position peaked at $1.16M in Q3 2014. 106 funds tracked by Wall St. Rank hold HPTX as of Q4 2014.

  • Macquarie Group reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • Macquarie Group sold 45,969 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $1.16M.
  • Macquarie Group first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q3 2013 and held it in 5 quarters.
  • Macquarie Group's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $1.16M in Q3 2014.
  • 106 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on Macquarie Group's 13F filing for Q4 2014, filed 17 Feb 2015.